Sort
48,018 grants matching “immunotherapy”
JOC-x: Chemotherapy conjugates that open tumor tight junctions to treat cancer
$556,615Darrick Albert Carter · Pai Life Sciences, Inc. · R44 · FY2020 · CA
Adoptive Transfer of Donor Tregs Specific Against Host Alloantigens for Presentio
$556,530Joseph A Pidala · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2017 · HL
Immune injury as a driver for the development of ascending aortic aneurysms and dissections
$556,529Zhihua Jiang · University Of Florida · R01 · FY2023 · HL
Interplay between host microbiome and immunomodulatory responses in the pathogenesis of Kras mutant lung cancer
$556,410Humam Kadara · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$556,372Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2022 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$556,372Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2021 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$556,357Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2020 · CA
Overcoming tumor heterogeneity in glioblastoma with multi-targeted CAR T cells secreting bispecific antibodies
$556,354Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2019 · CA
Quantitative Multimodal Imaging Biomarkers for Combined Locoregional and Immunotherapy of Liver Cancer
$556,171James S Duncan · Yale University · R01 · FY2024 · CA
CD8 T cell-dependent pathways leading to immunopathology in cutaneous leishmaniasis
$556,096Phillip A. Scott · University Of Pennsylvania · R01 · FY2020 · AI
Improving Patient Adherence to Cancer Treatment
$556,008University Of Southern California · R01 · FY2003 · CA
Understanding human neutralizing antibodies to hepatitis C virus
$556,005Mansun Law · Scripps Research Institute, The · R01 · FY2017 · AI
Understanding human neutralizing antibodies to hepatitis C virus
$556,005Mansun Law · Scripps Research Institute, The · R01 · FY2016 · AI
Targeting FOXP3 mRNA splicing for breast cancer immunotherapy
$555,952Baohua Zhou · Indiana University Indianapolis · R01 · FY2024 · CA
PEDIATRIC PHASE I TRIALS OF CYTOTOXIC &BIOLOGIC AGENTS
$555,947National Childhood Cancer Foundation · U01 · FY2001 · CA
Role of heat shock transcription factor HSF1 in tumorigenesis
$555,929Nahid F Mivechi · Augusta University · R01 · FY2020 · CA
Proj. 1 Targeting Tumor-Specific Neoepitopes for Glioblastoma Immunotherapy
$555,865David Reardon · Brigham And Women'S Hospital · P01 · FY2022 · CA
Spatial Mapping of Proteomic and Transcriptional Signatures in Kidney Disease
$555,864Joshua M Thurman · University Of Colorado Denver · U01 · FY2022 · DK
Spatial Mapping of Proteomic and Transcriptional Signatures in Kidney Disease
$555,864Joshua M Thurman · University Of Colorado Denver · U01 · FY2023 · DK
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
$555,814Elizabeth Repasky · Roswell Park Cancer Institute Corp · R01 · FY2022 · CA
Program stem-like CD8 T cells to enhance antiviral immunity against chronic viral infection
$555,764Tuoqi Wu · Ut Southwestern Medical Center · R01 · FY2025 · AI
Proj 3 - Targeting the Pro-tumorigenic Microenvironment
$555,724Yves A Declerck · Children'S Hosp Of Philadelphia · P01 · FY2021 · CA
Lung-Brain Coupling and the Immune Response to Acute Ischemic Stroke
$555,607Marc W Halterman · State University Of New York At Buffalo · R01 · FY2025 · NS
ANTI-HIV ANTIBODY IMMUNOTHERAPY IN HUPBL-SCID
$555,600Scripps Research Institute · R01 · FY2001 · HL
Neutrophil derived proteinases abolish the IFNG signature in NSCLC
$555,585A. McGarry Houghton · Fred Hutchinson Cancer Center · R01 · FY2024 · CA